Norepinephrine bitartrate 16 mg in 250 mL NaCl 0 — Class III drug recall D-0569-2022
Terminated recall by BayCare Integrated Service Center, LLC /dba BayCare Central Pharmacy, reported 2022-03-02, distributed in FL. Subpotent drug
| Recall number | D-0569-2022 |
|---|---|
| Product type | Drug |
| Classification | Class III |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | BayCare Integrated Service Center, LLC /dba BayCare Central Pharmacy, Temple Terrace, FL, United States |
| Recall initiated | 2022-02-14 |
| Classified | 2022-02-18 |
| Reported by FDA | 2022-03-02 |
| Terminated | 2022-12-08 |
| Distributed | FL |
| Quantity | 1,157 bags |
| Reason classes | potency |
| Lot numbers | NORE1620220111, NORE1620220113, NORE1620220118, NORE1620220125, NORE1620220127, NORE1620220202 |
| Expiration dates | 2022-03-31 |
Product
Norepinephrine bitartrate 16 mg in 250 mL NaCl 0.9%, packaged in IV bags, Rx only, BayCare Central Pharmacy 7802 E. Telecom Parkway Temple Terrace, FL 33637 (813) 901-6392
Reason for recall
Subpotent drug
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0569-2022. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.